To amend title XVIII of the Social Security Act to provide for certain cognitive impairment detection in the Medicare annual wellness visit and initial preventive physical examination.
- Sponsor
- Rep. Sánchez, Linda T. [D-CA-38]
- Committees
- Ways and Means Committee (primary)
- Last action
- May 19, 2025
Bottom line
This bill standardizes and strengthens cognitive impairment screening within Medicare's preventive services to facilitate earlier diagnosis and intervention for dementia.
What it actually does
This bill mandates that Medicare's annual wellness visits and initial preventive physical examinations include cognitive impairment detection using specific tools identified by the National Institute on Aging (NIA). It requires that the tool used and the assessment results be documented in the patient's medical record, with an effective date of January 1, 2026.
Proponents argue
Supporters argue that early detection of cognitive impairment is crucial for enabling timely access to care planning, medical treatments, support services, and clinical trials, as highlighted by the bill's findings on Alzheimer's disease. They emphasize the potential to mitigate the emotional and financial toll on patients and caregivers, address health disparities, and ultimately improve health outcomes while potentially reducing long-term healthcare costs associated with advanced dementia.
Opponents contend
Critics might raise concerns about the potential for increased healthcare costs due to more extensive screening and subsequent diagnostic workups, as well as the possibility of false positives leading to unnecessary anxiety and interventions. Some may also question the readiness of the healthcare system to handle a significant increase in early diagnoses, particularly regarding access to specialized care and support services.
The bill is very short and clear, allowing for quick comprehension by any interested reader.
Section 2(a), amending Section 1861(hhh)(2) of the Social Security Act.
Mandating NIA-Approved Cognitive Impairment Detection in Annual Wellness Visits
This provision requires that during a Medicare annual wellness visit, healthcare providers must use a specific cognitive impairment detection tool. This tool must be one that the National Institute on Aging (NIA) has identified as meeting its criteria for use in primary care settings. Additionally, the specific tool used and the results of the assessment must be thoroughly documented in the patient's medical record.
Supporters argue
Supporters argue this standardization ensures consistent, evidence-based screening, leading to earlier and more accurate diagnoses of cognitive decline. They contend that using NIA-approved tools improves the quality of care and facilitates timely interventions, aligning with the bill's findings on the benefits of early diagnosis for patients and caregivers.
Critics contend
Critics might argue that mandating specific tools could limit provider flexibility and potentially increase administrative burden or costs if new training or software is required. They may also express concern about the potential for over-screening or false positives, leading to unnecessary patient anxiety or further diagnostic expenses.
Tradeoffs
The provision balances the benefit of standardized, early detection against potential increases in administrative burden for providers and the healthcare system, as well as the psychological impact of screening results on patients.
Section 2(b), amending Section 1861(ww)(1) of the Social Security Act.
Extending NIA-Approved Cognitive Impairment Detection to Initial Preventive Physical Examinations
This provision extends the same requirement for standardized cognitive impairment detection to Medicare's initial preventive physical examinations (IPPE), often referred to as the "Welcome to Medicare" visit. Similar to the annual wellness visit, providers conducting an IPPE will be required to use an NIA-identified cognitive impairment detection tool and document the findings in the patient's medical record.
The bill mandates the use of cognitive impairment detection tools "identified by the National Institute on Aging as meeting its criteria for selecting instruments to detect cognitive impairment in the primary care setting."
Section 2(a)(1)(i) and Section 2(b)(1)
Why it matters:This is standard legislative practice to allow for flexibility and adaptation to evolving medical science and best practices without requiring new legislation for every update to screening tools. It avoids codifying specific tests that might become outdated.
Case for: Supporters argue that delegating the selection of specific tools to the NIA ensures that the mandated screenings remain current, evidence-based, and reflect the latest medical understanding of cognitive impairment detection. This flexibility allows for continuous improvement in screening protocols without legislative delays.
Case against: Critics might contend that by not specifying the tools, Congress cedes too much authority to an unelected body, potentially leading to the adoption of tools that could be more costly, time-consuming, or less appropriate for certain populations without direct legislative oversight.
Estimated impact: The specific impact on patients and providers depends entirely on the tools selected by the NIA, which could vary in duration, complexity, and cost.